Hotgen cTnI
Hotgen one-step cTnI is an accurate, rapid, semi-quantitative test for the determination of cardiac troponin I (cTnI) in human serum, plasma and whole blood as an aiding tool for early diagnosis of heart attack.
cTnI: the most specific cardiac marker for AMI
For more than 15 years cTnI has been known as a reliable marker of cardiac muscle tissue injury. It is considered to be more sensitive and significantly more specific in diagnosis of the myocardial infarction than Creatin Kinase isoenzyme MM (CK-MB) and myoglobin.
Measurements of cardiac troponin I are used in the diagnosis and treatment of myocardial infarction and as an aid in the risk stratification of patients with acute coronary syndromes with respect to their relative risk of mortality.
Currently it is widely practiced in the world that cTnI, CK-MB and myoglobin are co-measured in suspicion of MI.
Recently H-FABP has emerged as a very specific and sensitive cardiac biomarker for MI and the co-measurement of
cTnI: the most specific cardiac marker for AMI
For more than 15 years cTnI has been known as a reliable marker of cardiac muscle tissue injury. It is considered to be more sensitive and significantly more specific in diagnosis of the myocardial infarction than Creatin Kinase isoenzyme MM (CK-MB) and myoglobin.
Measurements of cardiac troponin I are used in the diagnosis and treatment of myocardial infarction and as an aid in the risk stratification of patients with acute coronary syndromes with respect to their relative risk of mortality.
Currently it is widely practiced in the world that cTnI, CK-MB and myoglobin are co-measured in suspicion of MI.
Recently H-FABP has emerged as a very specific and sensitive cardiac biomarker for MI and the co-measurement of
Certificate
- ISO13485
- CE
Main Products
Rapid test, UPTquik, cTnI, H-FABP, NT-proBNP, Anti-CCP, fFN